Article
Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-epsilon4 carriers.
The Journal of clinical psychiatry - 1 Oct 2009
Stonnington Cynthia M, Snyder Peter J, Hentz Joseph G, Reiman Eric M, Caselli Richard J
Abstract excerpt
OBJECTIVE: To examine cognitive effects of pharmacologically induced somnolence in cognitively normal carriers and noncarriers of the apolipoprotein E (APOE)-epsilon4 allele, a common Alzheimer's disease susceptibility gene. METHOD: Between December 2005 and July 2007, healthy and cognitively normal carriers of the APOE-epsilon4 allele (heterozygotes; n = 18) and noncarriers (n = 18), 50 to 65 years old,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
